K-134

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameK-134
Drug Alias NameOPC-33509K-134
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitors
TargetsPhosphodiesterase 3
Therapy Area/IndicationsIntermittent Claudication
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKowa Dental Health Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKowa Research Institute Inc
Active IndicationsN/A
Inactive IndicationsIntermittent Claudication

Other Information

ATC CodeN/A
Related LinksN/A